Ripple Therapeutics discovered that with a small amount of chemical engineering, drugs can be transformed into implantable prodrug materials. These materials undergo surface erosion, which results in the release of the active drug. Drug dose and duration can be precisely designed to meet therapeutic needs by tuning surface area and implant